SCIESCOPUSQ3
Vaccine: X
ELSEVIER, United Kingdom
Vaccine: X is an academic journal published by ELSEVIER (United Kingdom). Identifiers: ISSN 2590-1362, eISSN 2590-1362. Indexed in SCIE, SCOPUS. Metrics: JIF 2.2, CiteScore 3.5, SJR 0.686, SNIP 0.64. Subject areas: MEDICINE, RESEARCH & EXPERIMENTAL. tlooto lists 954 papers from this journal.
CiteScore
3.50
Scopus citation metric
SJR
0.686
SCImago rank
SNIP
0.64
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2590-1362
- eISSN
- 2590-1362
- Abbreviation
- VACCINE-X
- Publisher
- ELSEVIER
- Country
- United Kingdom
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
1313 Molecular Medicine2400 General Immunology and Microbiology2725 Infectious Diseases2739 Public Health3400 General Veterinary
Papers in this journal
Recent papers
- Estimating the cost of reaching zero-dose children in hard-to-reach regions of Ethiopia: the case of periodic intensification of routine immunization strategy
2026 · 1 citations
- Conspiracy beliefs and vaccination readiness among Japanese healthcare workers: A nationwide cross-sectional study (JACSIS 2024–2025)
2026
- Pneumococcal vaccine coverage and factors linked to second-dose administration in HIV patients in Andalusia (Spain), 2014–2022
2026
- Cost-effectiveness of High-Dose Influenza Vaccination in the Netherlands: Updated Analysis Incorporating New Evidence
2026
- Longitudinal survey of 6-monthly booster vaccination-induced antibody responses to equine influenza A virus (H3N8) in Standardbred trotting horses in training
2026
Most cited papers
- Educating healthcare providers to increase Human Papillomavirus (HPV) vaccination rates: A Qualitative Systematic Review
2019 · 119 citations
- “I’m scared that if I have the vaccine, it’s going to make my lung condition worse, not better.” COVID-19 vaccine acceptance in adults with underlying health conditions – A qualitative investigation
2022 · 119 citations
- Trust is the common denominator for COVID-19 vaccine acceptance: A literature review
2022 · 111 citations
- rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment
2019 · 87 citations
- What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
2020 · 81 citations